MedTrace Logo

Prolactin Hormone in Oral Lichen Planus

NCT04785703 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2021-03-08

No results posted yet for this study

Summary

Oral lichen planus (OLP) is one of the most common mucosal diseases with autoimmune etio-pathogenesis with involvement of various cytokines similar to psoriasis.It generally occurs more commonly in females, in a ratio of 3:2. prolactin (PRL),It is a peptide hormone that has a role in autoimmune related diseases like systemic lupus erythematosus and , rheumatoid Artheritis. The role of PrL in OLP pathogenesis was never investigated.the aim of this study is to investigate the expression of PRL receptors in tissue biopsies of OLP patients.

Conditions

  • Oral Lichen Planus

Sponsors & Collaborators

  • Al-Azhar University

    collaborator OTHER

  • October University for Modern Sciences and Arts

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-19
Primary Completion
2020-08-22
Completion
2020-12-10

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04785703 on ClinicalTrials.gov